New Orleans, LA1 Active Studies

Benign Prostatic Hyperplasia Clinical Trials in New Orleans, LA

Find 1 actively recruiting benign prostatic hyperplasia clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
206
Enrolling

Recruiting Benign Prostatic Hyperplasia Studies in New Orleans

About Benign Prostatic Hyperplasia Clinical Trials in New Orleans

Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that can cause urinary symptoms in men. It becomes increasingly common with age, affecting most men over 50. Treatment includes alpha-blockers, 5-alpha reductase inhibitors, and minimally invasive procedures.

There are currently 1 benign prostatic hyperplasia clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 206 participants. Research is being sponsored by Olympus Corporation of the Americas. Clinical trial participation is free and participants receive study-related medical care at no cost.

Benign Prostatic Hyperplasia Clinical Trials in New Orleans — FAQ

Are there benign prostatic hyperplasia clinical trials in New Orleans?

Yes, there are 1 benign prostatic hyperplasia clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What benign prostatic hyperplasia treatments are being tested?

The 1 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for benign prostatic hyperplasia.

Data updated July 13, 2026 from ClinicalTrials.gov